Tarrahlthistyl Profile
Key Indicators
- Authorised Capital ₹ 3.51 M
- Paid Up Capital ₹ 3.51 M
- Company Age 6 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -92.47%
- Profit Growth -5.44%
- Ebitda 16.99%
- Net Worth -28.76%
- Total Assets -54.02%
About Tarrahlthistyl
Tarrahlthistyl Private Limited (TPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 01 August 2018 (Six years and six months 25 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.51 M and a paid-up capital of Rs 3.51 M, as per Ministry of Corporate Affairs (MCA) records.
Shyamsundar Sarangapani and Chithra Babu serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999KA2018PTC115155
- Company No.
115155
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Aug 2018
- Date of AGM
20 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
What products or services does Tarrahlthistyl Private Limited offer?
Tarrahlthistyl Private Limited offers a wide range of products and services, including Health Conditions, Mental Wellness, Vitamins & Supplements, Multivitamins.
Who are the key members and board of directors at Tarrahlthistyl?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shyamsundar Sarangapani  | Director | 01-Aug-2018 | Current |
| Chithra Babu | Director | 01-Aug-2018 | Current |
Financial Performance of Tarrahlthistyl.
Tarrahlthistyl Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 92.47% decrease. The company also saw a slight decrease in profitability, with a 5.44% decrease in profit. The company's net worth observed a substantial decline by a decrease of 28.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tarrahlthistyl?
In 2022, Tarrahlthistyl had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sportmore Private LimitedShyamsundar Sarangapani is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Tarrahlthistyl?
Unlock and access historical data on people associated with Tarrahlthistyl, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tarrahlthistyl, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tarrahlthistyl's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.